The effects of exogenous surfactant treatment in a murine model of two-hit lung injury

Anesthesia and Analgesia

Volumn 120, Issue 2, 2015, Pages 381-388

  Zambelli, Vanessa ^a   Bellani, Giacomo ^a,b   Amigoni, Maria ^b   Grassi, Alice ^a   Scanziani, Margherita ^b   Farina, Francesca ^a   Latini, Roberto ^c   Pesenti, Antonio ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYTOKINE; HYDROCHLORIC ACID; PORACTANT; LUNG SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; INFLAMMATORY CELL; LEUKOCYTE COUNT; LUNG ALVEOLUS CELL; LUNG ALVEOLUS OXYGEN TENSION; LUNG COMPLIANCE; LUNG GAS EXCHANGE; LUNG INJURY; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PHYSIOLOGICAL PROCESS; PNEUMONIA; POST HOC ANALYSIS; PRIORITY JOURNAL; SURVIVAL; ANESTHESIA; ANIMAL; BLOOD GAS ANALYSIS; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; HEMODYNAMICS; LUNG ALVEOLUS; LUNG FUNCTION TEST; PATHOLOGY; RESPIRATORY DISTRESS SYNDROME, ADULT; TIDAL VOLUME; VENTILATOR INDUCED LUNG INJURY;

ANESTHESIA; ANIMALS; BLOOD GAS ANALYSIS; HEMODYNAMICS; HYDROCHLORIC ACID; LUNG COMPLIANCE; MALE; MICE; MICE, INBRED C57BL; PNEUMONIA; PULMONARY ALVEOLI; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY FUNCTION TESTS; TIDAL VOLUME; VENTILATOR-INDUCED LUNG INJURY;

EID: 84922015219     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000549     Document Type: Article

References (39)

1. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353: 1685-93
2. Bellani G, Messa C, Guerra L, Spagnolli E, Foti G, Patroniti N, Fumagalli R, Musch G, Fazio F, Pesenti A. Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: A [18F]-fluoro-2-deoxy-Dglucose PET/CT study. Crit Care Med 2009; 37: 2216-22
3. Bellani G, Guerra L, Musch G, Zanella A, Patroniti N, Mauri T, Messa C, Pesenti A. Lung regional metabolic activity and gas volume changes induced by tidal ventilation in patients with acute lung injury. Am J Respir Crit Care Med 2011; 183: 1193-9
4. Petty TL, Ashbaugh DG. The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management. Chest 1971; 60: 233-9
5. Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol 2011; 6: 147-63
6. Cepkova M, Matthay MA. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med 2006; 21: 119-43
7. Dreyfuss D, Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 1998; 157: 294-323
8. Muscedere JG, Mullen JB, Gan K, Slutsky AS. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 1994; 149: 1327-34
9. Slutsky AS. Lung injury caused by mechanical ventilation. Chest 1999; 116: 9S-15S
10. Tsuno K, Miura K, Takeya M, Kolobow T, Morioka T. Histopathologic pulmonary changes from mechanical ventilation at high peak airway pressures. Am Rev Respir Dis 1991; 143: 1115-20
11. Parker JC, Hernandez LA, Peevy KJ. Mechanisms of ventilatorinduced lung injury. Crit Care Med 1993; 21: 131-43
12. Slutsky AS, Tremblay LN. Multiple system organ failure. Is mechanical ventilation a contributing factor. Am J Respir Crit Care Med 1998; 157: 1721-5
13. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest 1982; 70: 673-83
14. Holm BA, Matalon S. Role of pulmonary surfactant in the development and treatment of adult respiratory distress syndrome. Anesth Analg 1989; 69: 805-18
15. Pison U, Seeger W, Buchhorn R, Joka T, Brand M, Obertacke U, Neuhof H, Schmit-Neuerburg KP. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am Rev Respir Dis 1989; 140: 1033-9
16. Schmidt R, Meier U, Yabut-Perez M, Walmrath D, Grimminger F, Seeger W, Günther A. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia. Am J Respir Crit Care Med 2001; 163: 95-100
17. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 147: 218-33
18. Albert RK, Lakshminarayan S, Hildebrandt J, Kirk W, Butler J. Increased surface tension favors pulmonary edema formation in anesthetized dogs' lungs. J Clin Invest 1979; 63: 1015-8
19. Lewis JF, Veldhuizen R. The role of exogenous surfactant in the treatment of acute lung injury. Annu Rev Physiol 2003; 65: 613-42
20. Willson DF, Notter RH. The future of exogenous surfactant therapy. Respir Care 2011; 56: 1369-86
21. Scanziani M, Amigoni M, Bellani G, Zambelli V, Masson S, Radaelli E, Pesenti A, Latini R. The effect of a single bolus of exogenous surfactant on lung compliance persists until two weeks after treatment in a model of acid aspiration pneumonitis. Pulm Pharmacol Ther 2011; 24: 141-6
22. Amigoni M, Bellani G, Zambelli V, Scanziani M, Farina F, Fagnani L, Latini R, Fumagalli R, Pesenti A. Unilateral acid aspiration augments the effects of ventilator lung injury in the contralateral lung. Anesthesiology 2013; 119: 642-51
23. Amigoni M, Bellani G, Scanziani M, Masson S, Bertoli E, Radaelli E, Patroniti N, Di Lelio A, Pesenti A, Latini R. Lung injury and recovery in a murine model of unilateral acid aspiration: functional, biochemical, and morphologic characterization. Anesthesiology 2008; 108: 1037-46
24. Stamme C, Brasch F, von Bethmann A, Uhlig S. Effect of surfactant on ventilation-induced mediator release in isolated perfused mouse lungs. Pulm Pharmacol Ther 2002; 15: 455-61
25. Vaneker M, Halbertsma FJ, van Egmond J, Netea MG, Dijkman HB, Snijdelaar DG, Joosten LA, van der Hoeven JG, Scheffer GJ. Mechanical ventilation in healthy mice induces reversible pulmonary and systemic cytokine elevation with preserved alveolar integrity. Anesthesiology 2007; 107: 419-26
26. McCallum L. Confidence interval calculation for proportion. Available at: https: //www. mccallum-layton. co. uk/tools/statisticcalculators/ confidence-interval-for-proportions-calculator/. Accessed July 30, 2014
27. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA 3rd, Hudson LD, Maunder RJ, Crim C, Hyers TM. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 88: 1976-81
28. Maruscak AA, Vockeroth DW, Girardi B, Sheikh T, Possmayer F, Lewis JF, Veldhuizen RA. Alterations to surfactant precede physiological deterioration during high tidal volume ventilation. Am J Physiol Lung Cell Mol Physiol 2008; 294: L974-83
29. Spragg RG, Gilliard N, Richman P, Smith RM, Hite RD, Pappert D, Robertson B, Curstedt T, Strayer D. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest 1994; 105: 195-202
30. Günther A, Schmidt R, Harodt J, Schmehl T, Walmrath D, Ruppert C, Grimminger F, Seeger W. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties. Eur Respir J 2002; 19: 797-804
31. Walmrath D, Grimminger F, Pappert D, Knothe C, Obertacke U, Benzing A, Günther A, Schmehl T, Leuchte H, Seeger W. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics. Eur Respir J 2002; 19: 805-10
32. Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, Häfner D, Taut FJ, Seeger W. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004; 351: 884-92
33. Kesecioglu J, Beale R, Stewart TE, Findlay GP, Rouby JJ, Holzapfel L, Bruins P, Steenken EJ, Jeppesen OK, Lachmann B. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2009; 180: 989-94
34. Willson DF, Thomas NJ, Markovitz BP, Bauman LA, DiCarlo JV, Pon S, Jacobs BR, Jefferson LS, Conaway MR, Egan EA; Pediatric Acute Lung Injury and Sepsis Investigators. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: A randomized controlled trial. JAMA 2005; 293: 470-6
35. Scholtes U, Wiegand N, Zwirner J, Herting E. Influence of porcine natural modified surfactant on chemotaxis and oxidative metabolism of polymorphonuclear leukocytes. Immunobiology 2002; 205: 290-302
36. Nieman GF, Gatto LA, Paskanik AM, Yang B, Fluck R, Picone A. Surfactant replacement in the treatment of sepsis-induced adult respiratory distress syndrome in pigs. Crit Care Med 1996; 24: 1025-33
37. Sun Y, Wang YQ, Yang R, Zhu JJ, Le YY, Zhong JG, Lu J. Exogenous porcine surfactants increase the infiltration of leukocytes in the lung of rats. Pulm Pharmacol Ther 2009; 22: 253-9
38. Carlos TM, Harlan JM. Membrane proteins involved in phagocyte adherence to endothelium. Immunol Rev 1990; 114: 5-28
39. Puntorieri V, Hiansen JQ, McCaig LA, Yao LJ, Veldhuizen RA, Lewis JF. The effects of exogenous surfactant administration on ventilation-induced inflammation in mouse models of lung injury. BMC Pulm Med 2013; 13: 67